BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chu G, Xu T, Zhu G, Liu S, Niu H, Zhang M. Identification of a Novel Protein-Based Signature to Improve Prognosis Prediction in Renal Clear Cell Carcinoma. Front Mol Biosci 2021;8:623120. [PMID: 33842538 DOI: 10.3389/fmolb.2021.623120] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Weaver C, Bin Satter K, Richardson KP, Tran LKH, Tran PMH, Purohit S. Diagnostic and Prognostic Biomarkers in Renal Clear Cell Carcinoma. Biomedicines 2022;10:2953. [DOI: 10.3390/biomedicines10112953] [Reference Citation Analysis]
2 Ji X, Chu G, Chen Y, Jiao J, Lv T, Yao Q. Comprehensive analysis of novel prognosis-related proteomic signature effectively improve risk stratification and precision treatment for patients with cervical cancer. Arch Gynecol Obstet 2022. [PMID: 35713693 DOI: 10.1007/s00404-022-06642-w] [Reference Citation Analysis]
3 Li Q, Su T, Shi W, Fang J, Zhang M, Xu Q, Liang R, Ge Q, Li B, Shao Y, Xie Z. Neuron-Specific Enolase and Hemoglobin as Risk Factors of Intraocular Metastasis in Patients with Renal Cell Carcinoma. Disease Markers 2022;2022:1-8. [DOI: 10.1155/2022/2883029] [Reference Citation Analysis]
4 Fang X, Liu X, Lu L, Liu G. Identification of a Somatic Mutation-Derived Long Non-Coding RNA Signatures of Genomic Instability in Renal Cell Carcinoma. Front Oncol 2021;11:728181. [PMID: 34676164 DOI: 10.3389/fonc.2021.728181] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
5 Li H, Chen L, Ke ZB, Chen SH, Xue XY, Zheng QS, Wei Y, Zeng K, Xu N. Angiogenesis-Related Molecular Subtypes and a Novel Prognostic Signature in Clear Cell Renal Cell Carcinoma Patients. Int J Gen Med 2021;14:6325-42. [PMID: 34629897 DOI: 10.2147/IJGM.S332732] [Reference Citation Analysis]
6 Zhao H, Zhang J, Fu X, Mao D, Qi X, Liang S, Meng G, Song Z, Yang R, Guo Z, Tong B, Sun M, Zuo B, Li G. Integrated bioinformatics analysis of the NEDD4 family reveals a prognostic value of NEDD4L in clear-cell renal cell cancer. PeerJ 2021;9:e11880. [PMID: 34458018 DOI: 10.7717/peerj.11880] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]